Loading...
Loading...
Hi-Tech Pharmacal
HITK announced today that the US Food and Drug Administration, (FDA)
granted final approval for the Company's Abbreviated New Drug
Application, (ANDA) for Bromfenac Ophthalmic Solution, 0.09%
(Once-A-Day), the generic for ISTA Pharmaceuticals' Bromday ® ophthalmic
solution, 0.09%. The product is used to treat postoperative inflammation
and reduction of ocular pain in patients who have undergone cataract
surgery. Hi-Tech plans to launch the product immediately.
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in